Royal Bank of Canada’s Alimera Sciences ALIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,015
| Closed | -$11K | – | 7672 |
|
|
2024
Q2 | $11K | Buy |
2,015
+1,993
| +9,059% | +$7.08K | ﹤0.01% | 6317 |
|
|
2024
Q1 | $0 | Hold |
22
| – | – | ﹤0.01% | 7757 |
|
|
2023
Q4 | $0 | Sell |
22
-23
| -51% | -$78 | ﹤0.01% | 7721 |
|
|
2023
Q3 | $0 | Hold |
45
| – | – | ﹤0.01% | 7751 |
|
|
2023
Q2 | $0 | Buy |
+45
| New | +$103 | ﹤0.01% | 7775 |
|
|
2018
Q4 | – | Sell |
-9
| Closed | – | – | 7211 |
|
|
2018
Q3 | $0 | Buy |
+9
| New | +$137 | ﹤0.01% | 7010 |
|
|
2018
Q1 | – | Sell |
-9
| Closed | – | – | 6893 |
|
|
2017
Q4 | $0 | Buy |
9
+8
| +800% | +$156 | ﹤0.01% | 6974 |
|
|
2017
Q3 | $0 | Buy |
+1
| New | +$21 | ﹤0.01% | 7049 |
|
|
2017
Q2 | – | Sell |
-1
| Closed | – | – | 6823 |
|
|
2017
Q1 | $0 | Buy |
+1
| New | +$19 | ﹤0.01% | 6874 |
|
|
2016
Q1 | – | Sell |
-10
| Closed | – | – | 6714 |
|
|
2015
Q4 | $0 | Sell |
10
-61
| -86% | -$2.65K | ﹤0.01% | 6858 |
|
|
2015
Q3 | $2K | Sell |
71
-39
| -35% | -$2.2K | ﹤0.01% | 6400 |
|
|
2015
Q2 | $8K | Buy |
+110
| New | +$7.59K | ﹤0.01% | 6137 |
|
|
2015
Q1 | – | Sell |
-1,667
| Closed | -$139K | – | 6461 |
|
|
2014
Q4 | $139K | Hold |
1,667
| – | – | ﹤0.01% | 4566 |
|
|
2014
Q3 | $136K | Buy |
+1,667
| New | +$142K | ﹤0.01% | 4440 |
|
|
2013
Q4 | – | Sell |
-26
| Closed | -$1K | – | 6194 |
|
|
2013
Q3 | $1K | Buy |
+26
| New | +$1.63K | ﹤0.01% | 5978 |
|
Royal Bank of Canada's ALIM Position: Q3 2024 in Review
Royal Bank of Canada sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 2,015 shares — an estimated $11K sold.
Royal Bank of Canada first reported a position in ALIM in Q3 2013 and held it in 15 quarters. The position peaked at $139K in Q4 2014. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.
- Royal Bank of Canada reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
- Royal Bank of Canada sold 2,015 Alimera Sciences shares in Q3 2024, an estimated $11K.
- Royal Bank of Canada first reported a position in Alimera Sciences in Q3 2013 and held it in 15 quarters.
- Royal Bank of Canada's Alimera Sciences position peaked at $139K in Q4 2014.
- 0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.
Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.